Biomarker-guided targeted and immunotherapies in malignant pleural mesothelioma.
Ther Adv Med Oncol. 2020 Nov 12;12:1758835920971421. doi: 10.1177/1758835920971421. eCollection 2020.
Ther Adv Med Oncol. 2020.
PMID: 33240401
Free PMC article.
Review.